Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Naz, F. Alatas, G. Durmaz, G. Ak, H. Yildirim, M. Metintas, S. Erginel (Eskisehir, Turkey). General evaluation in cases with community acquired pneumonia due to C. pneumoniae. Eur Respir J 2007; 30: Suppl. 51, 3939

Member's Comments

No comment yet.

Related content which might interest you: Streptococcus pneumoniae resistance pattern and its clinical implications Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Clinical aspects of chlamydia pneumoniae pneumonia in adults Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004 Chlamydia pneumoniae pneumonia and Mycoplasma pneumoniae pneumonia: comparison of clinical findings and CT findings Source: Eur Respir J 2004; 24: Suppl. 48, 488s Year: 2004 Comparative study of S. milleri as a cause of community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 373s Year: 2006 Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006 Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia Source: Eur Respir J 2011; 37: 1522-1524 Year: 2011 Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? Source: Eur Respir J 2003; 21: 741-742 Year: 2003 Penicillin-resistant streptococcus pneumoniae is a rare etiology of community-acquired pneumonia requiring hospitalization: results from the CAPO international cohort study Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001 Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized? Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Chlamydia species as a cause of community-acquired pneumonia in Canada Source: Eur Respir J 2003; 21: 779-784 Year: 2003 The radiological findings of Mycoplasma pneumoniae pneumonia from our 43 patients Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Bacterilogical profile of community acquired pneumoniae (CAP) in a respiratory disease department in Tunisia Source: Eur Respir J 2006; 28: Suppl. 50, 1s Year: 2006 Antibiotic treatment in community and hospital acquired pneumonia complicated by Clostridium difficile infection. Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia Source: Eur Respir J 2009; 34: 1148-1158 Year: 2009 Laboratory findings, physical and clinical features of mycoplasma pneumoniae infections. Analysis of 21 cases Source: Eur Respir J 2004; 24: Suppl. 48, 716s Year: 2004 Clinical features of Mycoplasma pneumoniae infections in Bulgarian children Source: Virtual Congress 2020 – Epidemiology of paediatric respiratory diseases Year: 2020 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002